TrialNature medicine2025

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial.

Matthias Preusser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.